VALVE COMPLICATIONS AND MANAGEMENT | SESSION TWO

Saturday, March 8, 2025

3:43 PM - 5:40 PM ET

Moderator(s)

Haim Danenberg, MD

Head of interventional cardiology
Wolfson Medical Center
Holon, Israel

Disclosure(s): Abbott Cardiovascular Systems: clinical proctor (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

No relationships to disclose
Michael Ragosta, MD

Director, Cardiac Catheterization Laboratory
University of Virginia
Charlottesville, Virginia, United States

No relationships to disclose

Panel Discussant(s)

Colin Barker, Sr., MD

Director
VUMC
Nashville, Tennessee, United States

No relationships to disclose
Suzanne J. Baron, MD, MSc

Interventional Cardiologist
Massachusetts General Hospital
Winchester, Massachusetts, United States

No relationships to disclose
Jeffrey E. Cohen, MD

Attending Cardiac Surgeon
Washington Hospital Center
Washington , District of Columbia, United States

No relationships to disclose
Santiago Garcia, MD

Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
The Christ Hospital
Cincinnati, Ohio, United States

No relationships to disclose
Michael R. Mooney, MD, FACC, FAHA, FSCAI

Director, Coronary Therapeutics
Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, Minnesota, United States

No relationships to disclose
Rishi Puri, MBBS PhD FRACP

Staff Structural and Coronary Interventionalist
Cleveland Clinic
Cleveland Heights, Ohio, United States

No relationships to disclose
Ranya N. Sweis, MD, MS

Interventional Cardiologist
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States

Disclosure information not submitted.
Steven J. Yakubov, MD, FACC, MSCAI

System/Medical Chief - Structural Heart Disease
OhioHealth/Riverside Methodist Hospital
Columbus, Ohio, United States

No relationships to disclose

Disclosure(s):

Haim Danenberg, MD: Abbott Cardiovascular Systems: clinical proctor (Ongoing)

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Michael Ragosta, MD: No financial relationships to disclose

Colin Barker, MD, Sr.: No financial relationships to disclose

Suzanne J. Baron, MD, MSc: Abiomed Inc: Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consultant (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jeffrey E. Cohen, MD: No financial relationships to disclose

Santiago Garcia, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Michael R. Mooney, MD, FACC, FAHA, FSCAI: No financial relationships to disclose

Rishi Puri, MBBS PhD FRACP: No financial relationships to disclose

Ranya N. Sweis, MD, MS: Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 29, 2023); Medtronic, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck & Co.: Chapter editor (Ongoing)

Steven J. Yakubov, MD, FACC, MSCAI: BioStar: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Foldax: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)